Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-29

Clinical Trial Update: A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01 [Phase 2]

View source ↗

Summary

Phase 2 continuation trial for rheumatoid arthritis subjects who completed protocol LBRA01 was terminated, with trial results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2011-06-29